首页> 外文OA文献 >NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN MANTLE CELL AND FOLLICULAR LYMPHOMA: THE TARGETED LOCUS AMPLIFICATION (TLA) NGS STRATEGY

【2h】

NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN MANTLE CELL AND FOLLICULAR LYMPHOMA: THE TARGETED LOCUS AMPLIFICATION (TLA) NGS STRATEGY

机译：甲状腺细胞和卵泡淋巴瘤中最小残留疾病（MRD）监测的新型分子标记：靶向轨迹扩增（TLA）NGS策略

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. Ferrero; E. Genuardi; P. Klous; D. Drandi; B. Mantoan; L. Monitillo; D. Barbero; M. Yilmaz; F. Cattellino; M. Vasta; F. Cavallo; S. Cortelazzo; U. Vitolo; S. Luminari; M. Federico; M. Boccadoro; E. Splinter; M. Ladetto;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Quantitative molecular monitoring of circulating lymphoma cells for the detection of minimal residual disease in follicular and mantle cell lymphoma. [J] . Schuler F, Hirt C, Dolken L, DMW: Deutsche Medizinische Wochenschrift . 2005,第38期

机译：对循环淋巴瘤细胞进行定量分子监测，以检测滤泡和套细胞淋巴瘤中的最小残留病。
2. Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells [J] . Schuler F, Hirt C, Dolken L, DMW: Deutsche Medizinische Wochenschrift . 2005,第38期

机译：滤泡和套细胞淋巴瘤的残留病最小。使用定量分子监测对循环淋巴瘤细胞进行检测
3. Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma. [J] . Brizova H, Krskova L, Kodet R International Journal of Cancer =: Journal International du Cancer . 2008,第12期

机译：定量监测细胞周期蛋白D1的表达：用于监测最小残留疾病的分子标记物，以及套细胞淋巴瘤患者疾病预后的预测因子。
4. ELEVATION OF MINIMAL RESIDUAL DISEASE (MRD) IN THE PERIPHERAL BLOOD PRIOR TO THE CLINICAL RELAPSE IN DOGS WITH LYMPHOMA THAT ACHIEVED COMPLETE REMISSION AFTER CHEMOTHERAPY [C] . Masahiko Sato, Junpei Yamazaki, Yuko Goto-Koshino, Annual Conference of the Veterinary Cancer Society . 2009

机译：在淋巴瘤患者临床复发之前在外周血中的最小残留疾病（MRD）升高，从而在化疗后取得完全缓解
5. Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study [O] . Morgane Cheminant, Coralie Derrieux, Aurore Touzart, 2016

机译：通过8色流式细胞仪监测套细胞淋巴瘤的最小残留疾病：EU-MCL和LYSA研究
6. Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting [O] . Paolo Corradini, Monica Astolfi, Cristina Cherasco, 1997

机译：用高剂量化疗和外周血祖细胞自体处理滤泡和披露细胞非霍格金淋巴瘤最小残留疾病的分子监测

NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) MONITORING IN MANTLE CELL AND FOLLICULAR LYMPHOMA: THE TARGETED LOCUS AMPLIFICATION (TLA) NGS STRATEGY

著录项

引文网络

相似文献

相关主题

期刊订阅